Stem cell therapy for sacroiliac joint dysfunction. MSC treatments address SI joint pain, reduce inflammation, and improve pelvic stability and mobility.
Stem cell therapy for sacroiliac (SI) joint dysfunction at StemCell Longevita in Istanbul targets the inflammation and cartilage damage causing chronic low back and pelvic pain. Our MSC treatments repair damaged SI joint tissue and restore pelvic stability without surgical fusion.
SI joint dysfunction causes pain through inflammation of the sacroiliac joint, cartilage degeneration, and ligamentous laxity. MSCs reduce joint inflammation, promote cartilage repair within the SI joint, and support strengthening of the surrounding ligamentous structures. This addresses both the pain and the underlying instability.
Patients with chronic SI joint pain, sacroiliitis, sacroiliac joint degeneration, and post-pregnancy SI joint dysfunction. Particularly beneficial for patients who have responded temporarily to SI joint injections and wish to avoid surgical SI joint fusion.
After diagnostic imaging and provocative SI joint testing, treatment involves systemic IV MSC infusion combined with fluoroscopic-guided intra-articular SI joint injection for targeted delivery.
Pain reduction within 2-4 weeks, improved pelvic stability and reduced catching/locking sensations within 1-3 months. Long-lasting relief compared to steroid injections, with many patients avoiding the need for surgical fusion.
Istanbul's spine specialists provide precise image-guided SI joint treatment. Regenerative SI joint therapy at 60-80% lower cost than US surgical or injection alternatives.
SI joint stem cell therapy from €6,500, including spine imaging review, guided injection, hotel, transfers, and follow-up.
Related treatments: Osteoarthritis Stem Cell Therapy | Spinal Osteoarthritis Stem Cell Therapy | Bone Fracture Stem Cell Therapy | Bursitis Stem Cell Therapy | Facet Syndrome Stem Cell Therapy